Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Co. stock logo
CNMD
CONMED
$69.88
-2.0%
$78.80
$69.78
$138.47
$2.15B1.33559,506 shs1.19 million shs
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$21.35
-0.4%
$19.94
$16.21
$25.75
$5.82B0.976,022 shs1,845 shs
LivaNova PLC stock logo
LIVN
LivaNova
$55.94
+1.7%
$53.92
$42.75
$59.86
$2.97B0.89614,870 shs977,319 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$2.55
+3.7%
$2.58
$1.92
$24.13
$127.19M1.99922,319 shs769,560 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Co. stock logo
CNMD
CONMED
-2.01%-4.02%-8.86%-25.46%-39.36%
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
-0.56%+9.05%+6.44%+0.14%-16.56%
LivaNova PLC stock logo
LIVN
LivaNova
+1.67%+7.85%+2.79%+12.01%+16.69%
Outset Medical, Inc. stock logo
OM
Outset Medical
+3.66%+18.06%+24.09%-26.30%-85.47%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Co. stock logo
CNMD
CONMED
4.8204 of 5 stars
3.41.02.54.31.90.04.4
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
1.5773 of 5 stars
2.23.00.00.01.71.71.9
Outset Medical, Inc. stock logo
OM
Outset Medical
1.5538 of 5 stars
3.22.00.00.03.10.80.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Co. stock logo
CNMD
CONMED
2.86
Moderate Buy$120.4372.35% Upside
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
2.33
HoldN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$64.4015.12% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
2.33
Hold$5.42112.42% Upside

Current Analyst Ratings

Latest GNGBY, LIVN, CNMD, and OM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/8/2024
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
4/5/2024
Outset Medical, Inc. stock logo
OM
Outset Medical
CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$6.00
3/27/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
2/26/2024
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $61.00
2/22/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.00
2/21/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$62.00 ➝ $72.00
2/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00 ➝ $70.00
2/1/2024
CONMED Co. stock logo
CNMD
CONMED
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$130.00 ➝ $100.00
2/1/2024
CONMED Co. stock logo
CNMD
CONMED
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$135.00 ➝ $115.00
2/1/2024
CONMED Co. stock logo
CNMD
CONMED
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$107.00 ➝ $98.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Co. stock logo
CNMD
CONMED
$1.24B1.73$5.83 per share11.99$27.13 per share2.58
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$3.00B1.94$1.60 per share13.35$10.53 per share2.03
LivaNova PLC stock logo
LIVN
LivaNova
$1.15B2.62$4.46 per share12.55$23.72 per share2.36
Outset Medical, Inc. stock logo
OM
Outset Medical
$130.38M1.01N/AN/A$2.45 per share1.04

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Co. stock logo
CNMD
CONMED
$64.46M$2.0434.2512.320.665.18%13.69%4.67%N/A
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$227.45M$0.8425.42N/A7.58%8.05%4.76%N/A
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M$0.32174.8216.70N/A1.53%12.23%6.47%5/1/2024 (Confirmed)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$172.80M-$3.50N/AN/AN/A-132.54%-102.50%-52.42%5/8/2024 (Confirmed)

Latest GNGBY, LIVN, CNMD, and OM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.60N/A+$0.60N/AN/AN/A  
5/1/2024N/A
LivaNova PLC stock logo
LIVN
LivaNova
$0.47N/A-$0.47N/AN/AN/A  
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    
2/21/2024Q4 2023
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.74-$0.77-$0.03-$0.77$30.40 million$30.51 million
2/1/2024Q4 2023
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A$0.29+$0.29$0.33N/A$930.96 million
1/31/2024Q4 2023
CONMED Co. stock logo
CNMD
CONMED
$1.11$1.06-$0.05$1.07$332.94 million$327.05 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Co. stock logo
CNMD
CONMED
$0.801.14%N/A39.22%N/A
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.241.12%N/A28.57%N/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A

Latest GNGBY, LIVN, CNMD, and OM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/24/2024
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.41644/23/20244/24/20245/14/2024
2/26/2024
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201%3/14/20243/15/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Co. stock logo
CNMD
CONMED
1.17
1.98
0.96
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
0.92
0.56
LivaNova PLC stock logo
LIVN
LivaNova
0.44
2.95
2.51
Outset Medical, Inc. stock logo
OM
Outset Medical
1.06
5.26
4.37

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CONMED Co. stock logo
CNMD
CONMED
N/A
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A

Insider Ownership

CompanyInsider Ownership
CONMED Co. stock logo
CNMD
CONMED
6.80%
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Outset Medical, Inc. stock logo
OM
Outset Medical
3.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Co. stock logo
CNMD
CONMED
4,00030.79 million28.70 millionOptionable
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
11,082272.37 millionN/ANot Optionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90053.96 million53.85 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
48051.70 million49.89 millionNot Optionable

GNGBY, LIVN, CNMD, and OM Headlines

SourceHeadline
Head to Head Survey: Endonovo Therapeutics (OTCMKTS:ENDV) & Outset Medical (NASDAQ:OM)Head to Head Survey: Endonovo Therapeutics (OTCMKTS:ENDV) & Outset Medical (NASDAQ:OM)
americanbankingnews.com - April 20 at 2:36 AM
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
finance.yahoo.com - April 19 at 1:30 PM
Outset Medical (OM) Inks Multi-Year Deal to Boost Home DialysisOutset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
zacks.com - April 18 at 2:41 PM
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
finance.yahoo.com - April 17 at 10:48 AM
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
businesswire.com - April 17 at 8:30 AM
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient CareOutset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
businesswire.com - April 15 at 8:30 AM
Outset Medical shares get Buy rating from BTIGOutset Medical shares get Buy rating from BTIG
investing.com - April 9 at 11:54 PM
Buy Rating And Bullish Price Target Sends Small Cap SoaringBuy Rating And Bullish Price Target Sends Small Cap Soaring
msn.com - April 8 at 5:51 PM
Outset Medical stock soars on optimistic analyst outlookOutset Medical stock soars on optimistic analyst outlook
massdevice.com - April 8 at 5:51 PM
Outset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue GrowthOutset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue Growth
markets.businessinsider.com - April 8 at 12:49 PM
BTIG Research Initiates Coverage on Outset Medical (NASDAQ:OM)BTIG Research Initiates Coverage on Outset Medical (NASDAQ:OM)
marketbeat.com - April 8 at 8:01 AM
Outset Medical (NASDAQ:OM) Upgraded to "Buy" at CL KingOutset Medical (NASDAQ:OM) Upgraded to "Buy" at CL King
marketbeat.com - April 5 at 8:20 AM
AO’s Treatment of Cash Deposits as Unexplained Without Adverse Material UnjustifiedAO’s Treatment of Cash Deposits as Unexplained Without Adverse Material Unjustified
taxguru.in - April 4 at 2:08 PM
Care Plan Your Doctor Would Usually Recommend For Acute Otitis MediaCare Plan Your Doctor Would Usually Recommend For Acute Otitis Media
msn.com - March 18 at 10:01 PM
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of DirectorsOutset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
businesswire.com - March 13 at 4:02 PM
Why Dialysis Stocks Are up TodayWhy Dialysis Stocks Are up Today
wsj.com - March 6 at 7:03 PM
Outset Medical to Present at the 44th Annual TD Cowen Health Care ConferenceOutset Medical to Present at the 44th Annual TD Cowen Health Care Conference
businesswire.com - February 26 at 9:00 AM
Outset Medical Full Year 2023 Earnings: EPS Misses ExpectationsOutset Medical Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - February 23 at 8:48 AM
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)
markets.businessinsider.com - February 22 at 12:21 PM
Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call TranscriptOutset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 22 at 12:21 PM
Q4 2023 Outset Medical Inc Earnings CallQ4 2023 Outset Medical Inc Earnings Call
finance.yahoo.com - February 22 at 7:19 AM
Outset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlookOutset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlook
msn.com - February 21 at 5:51 PM
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsOutset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 21 at 5:51 PM
Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 ResultsOutset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results
finance.yahoo.com - February 21 at 5:51 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CONMED logo

CONMED

NYSE:CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Getinge AB (publ) logo

Getinge AB (publ)

OTCMKTS:GNGBY
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Outset Medical logo

Outset Medical

NASDAQ:OM
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.